Golden State Equity Partners Invitae Corp Transaction History

Golden State Equity Partners

  • $182 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 01, 2023
SELL
$1.2 - $2.73 $33,990 - $77,327
-28,325 Closed
0 $0
Q1 2022

May 18, 2022
BUY
$6.28 - $15.59 $177,881 - $441,586
28,325 New
28,325 $226,000
Q1 2022

May 16, 2022
SELL
$6.28 - $15.59 $145,853 - $362,077
-23,225 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$14.7 - $28.67 $341,407 - $665,860
23,225 New
23,225 $355,000

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email